Halyard Health Introduces ON-Q* TRAC Online Patient Engagement Platform to Improve the Post-Operative Patient Experience
Real-Time Feedback Helps Physicians and Hospitals Enhance Treatment and Patient Experience(1)

SAN DIEGO, March 14, 2017 /PRNewswire/ -- AAOS Annual Meeting, Booth #833 -- Halyard Health (NYSE: HYH), a medical technology company focused on eliminating pain, speeding recovery and preventing infection, today introduced ON-Q* TRAC, an online patient engagement platform developed to help physicians and hospitals provide better post-operative patient care by delivering real-time patient feedback. By implementing ON-Q TRAC, physicians can monitor, measure and track patients' post-operative satisfaction to improve the overall patient experience.1

ON-Q TRAC helps engage patients, enhance connectivity and improve collaboration between patients and physicians. Patients are enrolled in the platform before surgery and are invited to provide information at various time intervals – from pre-operative through 90-days post-surgery – via a user-friendly survey that can be completed on either a desktop or mobile device. Based on this patient input, physicians are able to track patients' pain levels and satisfaction with their treatment and care.

Using insights provided by ON-Q TRAC, physicians can proactively intervene and adjust patient care for improved outcomes. This can include reducing opioid consumption, ER visits and hospital readmissions. Studies show that increased physician to patient connectivity enhances patient satisfaction scores, helps improve outcomes and can boost reputation and referrals.1,2,3,4,5,6,7

ON-Q TRAC's aggregate dashboards allow hospital administrators to detect and analyze data, identify trends and adjust protocols quickly to ensure consistent standards of care are met across procedures. This information can be used to manage costs for hospitals that are participating in the Comprehensive Total Joint Replacement (CJR) program.

"Patients expect their physicians to be engaged from diagnosis through recovery, and with new requirements of the CJR program, hospitals are even more focused on increasing the quality of patient care and satisfaction. ON-Q TRAC makes it easier for busy physicians and hospital staff to keep the lines of communication open with patients, enabling treatment decisions that are based on real-time information for better clinical success and improved patient outcomes," said Roger Massengale, general manager, acute pain, Halyard Health. "Halyard is focused on speeding recovery for healthcare providers and patients by reducing the need for opioids, and ON-Q TRAC is another important tool in our suite of products focused on improving post-operative recovery."

To learn more about ON-Q TRAC, click here.

About Halyard Health

Halyard Health (NYSE: HYH) is a medical technology company focused on eliminating pain, speeding recovery and preventing infection for healthcare providers and their patients. Headquartered in Alpharetta, Georgia, Halyard is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery and preventing healthcare-associated infections. Halyard's business segments - Medical Devices and Surgical and Infection Prevention (S&IP) - develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. For more information, visit www.halyardhealth.com.

*Registered Trademarks or Trademarks of Halyard Health, Inc. or its affiliates. 

1 Hachem F, Canar J, Fullam F, Gallan A, Hohmann S, Johnson C. The relationships between HCAHPS communication and discharge satisfaction items and hospital readmissions. Patient Experience Journal. 2014; Vol. 1: Iss. 2, Article 12.

2 Heller L, Kowalski AM, Wei C, Butler CE. Prospective, randomized, double-blind trial of local anesthetic infusion and intravenous narcotic patient-controlled anesthesia pump for pain management after free TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;122(4):1010-1018.

3 Liu SS, Richman JM, Thirlby RC, Wu CL. Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg. 2006;203(6):914-932.

4 Beaussier M, El'Ayoubi H, Schiffer E, et al. Continuous preperitoneal infusion of ropivacaine provides effective analgesia and accelerates recovery after colorectal surgery. Anesthesiology. 2007;107(3):461-468.

5 Bingham AE, Fu R, Horn JL, Abrahams MS. Continuous peripheral nerve block compared with single-injection peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2012;37(6):583-594.

6 Kean J, Wigderowitz CA, Coventry DM. Continuous interscalene infusion and single injection using levobupivacaine for analgesia after surgery of the shoulder: a double-blind, randomized controlled trial. J Bone Joint Surg [Br]. 2006;88-B:1173-1177.

7 Husain A, Lee GC. Establishing realistic patient expectations following total knee arthroplasty. J Am Acad Orthop Surg. 2015;23(12):707-713.


SOURCE Halyard Health

For further information: Jennifer Asaro, MSLGROUP, (781) 684-0770, ON-Q@mslgroup.com